BELLUS Health Inc
TSX:BLU
BELLUS Health Inc
TSX:BLU
Price:
19.48 CAD
-0.1%
Market Closed
Updated:
May 2, 2024
BELLUS Health Inc
Cash from Operating Activities
|
BELLUS Health Inc
Cash from Operating Activities Peer Comparison
Comparables:
ZYME
RPTX
FUSN
AUPH
EDT
Competitive Cash from Operating Activities Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Cash from Operating Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
BELLUS Health Inc
TSX:BLU
|
Cash from Operating Activities
-$89.2m
|
CAGR 3-Years
-46%
|
CAGR 5-Years
-79%
|
CAGR 10-Years
-40%
|
|
|
Zymeworks Inc
NYSE:ZYME
|
Cash from Operating Activities
-$118.3m
|
CAGR 3-Years
8%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Repare Therapeutics Inc
NASDAQ:RPTX
|
Cash from Operating Activities
-$127.2m
|
CAGR 3-Years
-176%
|
CAGR 5-Years
-59%
|
CAGR 10-Years
N/A
|
|
|
Fusion Pharmaceuticals Inc
NASDAQ:FUSN
|
Cash from Operating Activities
-$81.8m
|
CAGR 3-Years
-40%
|
CAGR 5-Years
-53%
|
CAGR 10-Years
N/A
|
|
|
Aurinia Pharmaceuticals Inc
NASDAQ:AUPH
|
Cash from Operating Activities
-$33.5m
|
CAGR 3-Years
22%
|
CAGR 5-Years
8%
|
CAGR 10-Years
-22%
|
|
|
Spectral Medical Inc
TSX:EDT
|
Cash from Operating Activities
-CA$10.7m
|
CAGR 3-Years
-222%
|
CAGR 5-Years
-35%
|
CAGR 10-Years
-2%
|
See Also
What is BELLUS Health Inc's Cash from Operating Activities?
Cash from Operating Activities
-89.2m
USD
-89.2m
USD
Based on the financial report for Mar 31, 2023, BELLUS Health Inc's Cash from Operating Activities amounts to -89.2m USD.
What is BELLUS Health Inc's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 10Y
-40%
-40%
Over the last year, the Cash from Operating Activities growth was -48%. The average annual Cash from Operating Activities growth rates for BELLUS Health Inc have been -46% over the past three years , -79% over the past five years , and -40% over the past ten years .
You don't have any saved screeners yet
